Moelis & Company (MC) Stock Price & How to Invest

Last updated November 2026

Short answer

MC is Moelis & Company, an independent investment bank that earns advisory fees on mergers, restructurings, and capital raising, so it trades as a high-beta play on the deal cycle rather than a steady compounder. As of November 20, 2026 the shares sit near $52.32, down about 26.5% year to date and 14% over a year, just above their 52-week low, even as revenue keeps growing.

MC stock price

As of 2026-11-20, Moelis & Company (MC) last closed at $51.35, down 18.1% over the past year. Over the past 52 weeks it has traded between $51.35 and $77.75.

MC last close
$51.35
1 day
-4.02%
1 month
-3.22%
1 year
-18.13%
52-week range
$51.35 to $77.75
Last close
2026-11-20

Prices are daily closing prices from Yahoo Finance and may be delayed. For the live quote, check your broker or Moelis & Company's investor relations page. Walnut is informational, not investment advice.

MC key stats

At $51.35 on November 20, 2026, Moelis & Company (MC) has a market cap of $3.8B, a P/E of 17.5 on trailing earnings (14.0 on forward earnings) and a dividend yield of 5.06%. It next reports earnings around February 3, 2027 (estimated).

Market cap
$3.8B
P/E (trailing)
17.5
P/E (forward)
14.0
EPS (trailing 12 months)
$2.93
Price to book
7.1
Dividend yield
5.06%
Beta
1.84
Next earnings
around February 3, 2027 (estimated)

Market cap, P/E and yield are measured at the $51.35 price on November 20, 2026, from Yahoo Finance figures pulled in November 2026. Earnings date from Yahoo Finance. Walnut is informational, not investment advice.

What's new with Moelis & Company (MC)?

The last two weeks for Moelis & Company, as of November 22, 2026: the price move, the next earnings date, what the company filed with the SEC, and what analysts changed.

  • MC closed at $51.35 on November 20, 2026, down 8.3% over the past five trading days (from $56.00).
  • Moelis & Company next reports quarterly results around February 3, 2027 (estimated).
  • On November 9, 2026, Morgan Stanley lowered its target to $73.00 from $77.00 (Overweight).

Moelis & Company filed no current, quarterly or annual report with the SEC in the last two weeks.

Prices are daily closes from Yahoo Finance. Filings are read from SEC EDGAR every six hours. Analyst actions come from Yahoo Finance as of November 2026. Walnut is informational, not investment advice.

What does Moelis & Company (MC) do?

Moelis & Company is a global independent investment bank founded in 2007 by Ken Moelis. It advises corporations, governments, and financial sponsors on mergers and acquisitions, restructurings and liability management, private capital raising, and other strategic matters. Unlike bulge-bracket banks, Moelis takes no principal trading or lending risk, so essentially all of its revenue comes from advisory fees earned when transactions close. The firm competes at the large-cap end of the market against other elite independents while also running a well-regarded restructuring practice that tends to stay busy when deal-making cools.

The investment picture is cyclical and people-driven. Revenue swings with the pace of M&A and restructuring activity, and results can be lumpy quarter to quarter because fees are tied to closings. Moelis returns a large share of earnings to shareholders through a dividend and has been investing in senior banker hires to expand coverage. For 2026, management has pointed to a near record backlog of announced transactions and a constructive M&A outlook, balanced against risks from geopolitical uncertainty and disruption in private credit markets that can slow closings. Recent numbers show a business still growing but not by enough to satisfy the market. Third-quarter 2026 revenue, reported November 5, was about $426 million, up roughly 19% year over year but a little short of the roughly $438 million analysts had expected, while EPS of $0.75 edged past the $0.73 consensus. That followed a second quarter of about $409 million with EPS of $0.63 against $0.61, and a first quarter in which EPS of $0.50 missed. Trailing revenue is about $1.64 billion and trailing net income about $234 million. The shares closed at about $52.32 on November 20, 2026, down roughly 26.5% year to date, 23% over three months and 14% over a year, near the bottom of a 52-week range of $51.06 to $78.22. Fourth-quarter results are expected around February 3, 2027, with analysts looking for EPS of about $1.10 on roughly $542 million of revenue.

What's driving Moelis & Company (MC)?

1. M&A recovery and large-cap momentum

Moelis reported strength in large-cap M&A and a double-digit increase in sponsor-related M&A revenue in early 2026. Management describes a near all-time-high pipeline and points to corporates seeking scale amid technological disruption as a structural tailwind for advisory demand. Third-quarter 2026 revenue of about $426 million, up roughly 19% from a year earlier, kept that growth visible, and the firm continues to win high-profile mandates, including being hired in October 2026 as the Friedkin Group explores a sale of a controlling stake in Everton Football Club. Analysts expect 2027 revenue of about $2.01 billion, up from roughly $1.69 billion expected for 2026, which assumes the backlog converts into closings.

2. Restructuring and liability management

The firm has a deep restructuring and liability-management practice that generates fees when companies face distress, providing a partial counterweight when M&A slows. Continued demand for liquidity solutions and capital-structure work can smooth the cyclical swings in transaction advisory.

3. Private capital advisory expansion

Private capital advisory has become a growing contributor, helping sponsors raise funds and secure liquidity. Management flags a strong backlog here as private markets keep expanding and general partners seek continuation and secondary solutions.

4. Senior banker hiring and capital return

Moelis has been adding managing directors to widen sector and geographic coverage, which raises near-term compensation costs but builds future revenue capacity. The firm returns substantial cash to shareholders, paying a regular quarterly dividend of $0.65 per share ($2.60 a year) alongside buybacks. At the November 2026 price that works out to a yield near 4.9%, though the payout ratio of roughly 89% of trailing earnings leaves little room if profits dip.

What are the risks to Moelis & Company (MC)?

Advisory revenue is highly cyclical and tied to the pace of deal closings, so a slowdown in M&A or capital markets can compress results quickly. Compensation is the largest expense and rising banker pay can squeeze margins even when revenue grows. Geopolitical uncertainty and disruption in private credit markets can delay transactions, and the business depends heavily on retaining a relatively small group of senior rainmakers. First-quarter 2026 adjusted EPS of $0.50 came in below the $0.53 analysts expected, and the second and third quarters beat by only two cents each, while third-quarter revenue of about $426 million fell short of the roughly $438 million consensus, so results remain sensitive to costs and timing. The stock has fallen about 26.5% in 2026 and keeps testing its 52-week low, and the average analyst rating is Hold, so sentiment toward deal-driven names is a risk of its own. The dividend payout ratio near 89% of trailing earnings is another pressure point if fees slow.

What is the Moelis & Company (MC) forecast?

10 analysts publish price targets on MC, averaging $65.70 as of November 2026, or +27.9% against the $51.35 share price on November 20, 2026. The published targets run from $56.00 to $75.00, a narrow spread, and the ratings split 4 buy, 6 hold, 1 sell. Over the last six months there have been 2 raises and 6 cuts among the published actions. A price target is what an analyst published on a date, not a prediction, and sell-side ratings skew positive across the whole market.

Read the full MC forecast and price target for the target table, the recent rating actions by firm, and how the consensus has shifted.

Is MC a buy or a sell?

We give no verdict on Moelis & Company. Both cases are real, which is why the question is contested at all, so here is the strongest version of each.

The case for buying. M&A recovery and large-cap momentum. Moelis reported strength in large-cap M&A and a double-digit increase in sponsor-related M&A revenue in early 2026. The most optimistic published target, $75.00, assumes this works close to its best case.

The case against. Advisory revenue is highly cyclical and tied to the pace of deal closings, so a slowdown in M&A or capital markets can compress results quickly. The most pessimistic target, $56.00, is roughly what MC is worth if this bites instead.

Read the full bull and bear case on MC, including what would have to change to break either one. Walnut is not an investment adviser.

Has Moelis & Company (MC) split its stock?

No. Moelis & Company (MC) has not split its stock in the last 10 years. The statement covers only the window we check, so an older split in the company’s history is possible. It also matters less than it once did: fractional shares mean a high price per share no longer keeps smaller investors out, which removed most of the practical reason to split.

How is Moelis & Company (MC) valued?

Market cap, P/E and dividend yield at today's price are in the MC key stats above. The business figures below come from Moelis & Company's reported results as of November 2026 and change when it next reports.

  • Revenue (TTM): ~$1.64B (+19% YoY latest quarter)
  • Q3 2026 revenue: ~$426M vs ~$438M est.
  • Q3 2026 EPS: ~$0.75 vs ~$0.73 est.
  • Operating / net margin: ~20% / ~14%

As of November 2026: Moelis trades around $52.32 per share as of November 20, 2026, near the bottom of a 52-week range of roughly $51 to $78. That is about 18 times trailing and 14 times forward earnings, down from the mid-20s trailing multiple earlier in the year, as the market discounts a slower path for the deal cycle. Analysts expect 2026 revenue of about $1.69 billion and roughly $2.01 billion in 2027, with a mean price target near $65.70 across 10 analysts and a Hold consensus, so the early-February fourth-quarter report (consensus EPS about $1.10) is the next test of whether the backlog is converting.

Who competes with Moelis & Company (MC)?

Elite independent advisory firms

Evercore, Lazard, PJT Partners, Centerview, and Perella Weinberg compete directly with Moelis for large-cap M&A and restructuring mandates, all selling conflict-free advice without balance-sheet lending.

Bulge-bracket banks

Goldman Sachs, Morgan Stanley, and JPMorgan pursue the same large-cap advisory assignments, bundling financing and trading, which the independents position against by emphasizing independence from lending relationships.

Restructuring and middle-market specialists

Houlihan Lokey and Guggenheim Securities are strong in restructuring, while mid-market advisers like William Blair and Lincoln International compete on smaller transactions where Moelis is less focused.

What stocks are similar to Moelis & Company (MC)?

Other names that sit close to MC: same theme, named as a direct competitor, or held beside it in the same funds. Each entry says which. They are useful if you want to spread one thesis across several tickers.

How to invest in Moelis & Company (MC)

There are three common ways to get MC exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it, which spreads the position across many companies. Or build it into a focused thematic portfolio, so MC sits alongside other stocks that express the same thesis.

Walnut takes the portfolio route. Describe a thesis where MC fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.

New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.

The bottom line on Moelis & Company (MC)

Owning MC is a bet that the M&A and restructuring advisory cycle stays constructive, with a healthy dividend as the ballast between deal-flow swings. At today's price that dividend yields about 4.9%. The third quarter grew revenue about 19% and narrowly beat on EPS, but the stock kept sliding, and the next read is fourth-quarter results expected in early February 2027.

More on Moelis & Company (MC)

Whether MC is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is MC a buy or a sell?, and where the stock could go from here in the MC stock forecast.

For income investors, whether MC pays a dividend and how the payout looks is covered in does MC pay a dividend? And to weigh MC against a peer, read the full side-by-side comparisons: MC vs EVR and MC vs LAZ.

Wondering how MC fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.

Your questions about Moelis & Company

Ask Walnut's AI anything about MC and see how it fits what you own.

FAQ

What does the ticker MC stand for?

+

MC is the NYSE ticker for Moelis & Company, a global independent investment bank headquartered in New York. It should not be confused with unrelated foreign-listed companies that use similar symbols.

What does Moelis & Company actually do?

+

Moelis advises clients on mergers and acquisitions, restructurings and liability management, private capital raising, and other strategic matters. It earns fees for advice and does not take trading or lending risk on its own balance sheet.

How does Moelis make money?

+

Almost all of Moelis's revenue comes from advisory fees paid when transactions close or milestones are met. Because fees are event-driven, revenue can be lumpy from quarter to quarter and is sensitive to the overall deal environment.

Is Moelis stock cyclical?

+

Yes. Advisory revenue rises and falls with the M&A and capital-markets cycle. The restructuring practice tends to stay busier during downturns, which partially offsets weaker M&A, but overall results remain cyclical.

Does Moelis pay a dividend?

+

Moelis pays a regular quarterly dividend of $0.65 per share, or $2.60 a year, for a yield of roughly 4.9% at the November 2026 price. The firm has historically also returned cash through special dividends and buybacks, though these vary with earnings.

How did Moelis perform in early 2026?

+

First quarter 2026 revenue was about $320 million, up 4% year over year and a record for the period, while adjusted earnings per share of roughly $0.50 came in below analyst expectations. Management cited strength in large-cap M&A and private capital advisory.

Who are Moelis's main competitors?

+

Its closest peers are elite independent advisers such as Evercore, Lazard, PJT Partners, Centerview, and Perella Weinberg, along with bulge-bracket banks on large deals and Houlihan Lokey in restructuring.

How did Moelis do in its latest quarter?

+

Third-quarter 2026 revenue, reported November 5, was about $426 million, up roughly 19% year over year, though below the roughly $438 million analysts expected. EPS of $0.75 edged past the $0.73 consensus, and net income was about $59 million. Fourth-quarter results are expected around February 3, 2027, with consensus near $1.10 of EPS on about $542 million of revenue.

How has MC stock performed in 2026?

+

MC closed at about $52.32 on November 20, 2026, down roughly 26.5% year to date, 23% over three months and 14% over the past year, just above its 52-week low of about $51.06. In early October KBW upgraded the stock to Outperform with a $66 target and UBS moved it up to Neutral at $59, while BofA trimmed its target to $68; the average of 10 analyst targets is now near $65.70, with a Hold consensus.

What are the main risks to Moelis?

+

Key risks include a slowdown in deal activity, rising compensation costs that pressure margins, dependence on a small group of senior bankers, and macro or private-credit disruptions that delay transaction closings. Walnut is not an investment adviser, so weigh these factors against your own goals.

Walnut is informational, not investment advice. Financial figures on this page are approximations; always verify current numbers with Moelis & Company's investor relations page or your broker before making investment decisions.